Abstract
The purpose of the study was to update the current status of laparoscopic retroperitoneal lymph node dissection in the treatment of clinical Stage I nonseminomatous germ cell testicular cancer. A literature search was conducted to evaluate laparoscopic retroperitoneal lymph node dissection (RPLND) in comparison to other modalities of treatment. All treatment modalities are effective in treating clinical Stage I nonseminomatous germ cell tumors. Morbidity is the major issue that may guide treatment decisions. Laparoscopic RPLND, in its therapeutic form, may replicate open RPLND with a minimally invasive approach. Laparoscopic RPLND is an effective alternative to traditional treatment options.
Original language | English |
---|---|
Pages (from-to) | 145-148 |
Number of pages | 4 |
Journal | Urologic Oncology: Seminars and Original Investigations |
Volume | 22 |
Issue number | 2 |
DOIs | |
State | Published - Mar 1 2004 |
Keywords
- Germ cell tumor
- Lymphadenectomy
- Retroperitoneal lymph node dissection
- Testis cancer